These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15055990)

  • 1. Design and syntheses of 1,6-naphthalene derivatives as selective HCMV protease inhibitors.
    Gopalsamy A; Lim K; Ellingboe JW; Mitsner B; Nikitenko A; Upeslacis J; Mansour TS; Olson MW; Bebernitz GA; Grinberg D; Feld B; Moy FJ; O'Connell J
    J Med Chem; 2004 Apr; 47(8):1893-9. PubMed ID: 15055990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of pyrrolidine-5,5'-trans-lactams (5-oxo-hexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 4. Antiviral activity and plasma stability.
    Borthwick AD; Davies DE; Ertl PF; Exall AM; Haley TM; Hart GJ; Jackson DL; Parry NR; Patikis A; Trivedi N; Weingarten GG; Woolven JM
    J Med Chem; 2003 Oct; 46(21):4428-49. PubMed ID: 14521407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid-phase parallel synthesis and SAR of 4-amidofuran-3-one inhibitors of cathepsin S: effect of sulfonamides P3 substituents on potency and selectivity.
    Ayesa S; Lindquist C; Agback T; Benkestock K; Classon B; Henderson I; Hewitt E; Jansson K; Kallin A; Sheppard D; Samuelsson B
    Bioorg Med Chem; 2009 Feb; 17(3):1307-24. PubMed ID: 19124252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of pyrrolidine-5,5-trans-lactams (5-oxohexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 2. Potency and chirality.
    Borthwick AD; Crame AJ; Ertl PF; Exall AM; Haley TM; Hart GJ; Mason AM; Pennell AM; Singh OM; Weingarten GG; Woolven JM
    J Med Chem; 2002 Jan; 45(1):1-18. PubMed ID: 11754575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and molecular modelling studies of novel sulphonamide derivatives as dengue virus 2 protease inhibitors.
    Timiri AK; Selvarasu S; Kesherwani M; Vijayan V; Sinha BN; Devadasan V; Jayaprakash V
    Bioorg Chem; 2015 Oct; 62():74-82. PubMed ID: 26247308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small molecule antagonists of the CC chemokine receptor 4 (CCR4).
    Burdi DF; Chi S; Mattia K; Harrington C; Shi Z; Chen S; Jacutin-Porte S; Bennett R; Carson K; Yin W; Kansra V; Gonzalo JA; Coyle A; Jaffee B; Ocain T; Hodge M; LaRosa G; Harriman G
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3141-5. PubMed ID: 17395464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel series of highly selective inhibitors of MMP-3.
    Whitlock GA; Dack KN; Dickinson RP; Lewis ML
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6750-3. PubMed ID: 18029177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From 1-acyl-beta-lactam human cytomegalovirus protease inhibitors to 1-benzyloxycarbonylazetidines with improved antiviral activity. A straightforward approach to convert covalent to noncovalent inhibitors.
    Gerona-Navarro G; Pérez de Vega MJ; García-López MT; Andrei G; Snoeck R; De Clercq E; Balzarini J; González-Muñiz R
    J Med Chem; 2005 Apr; 48(7):2612-21. PubMed ID: 15801851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of potent inhibitors of human beta-secretase. Part 1.
    Freskos JN; Fobian YM; Benson TE; Bienkowski MJ; Brown DL; Emmons TL; Heintz R; Laborde A; McDonald JJ; Mischke BV; Molyneaux JM; Moon JB; Mullins PB; Bryan Prince D; Paddock DJ; Tomasselli AG; Winterrowd G
    Bioorg Med Chem Lett; 2007 Jan; 17(1):73-7. PubMed ID: 17046251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges in modern drug discovery: a case study of boceprevir, an HCV protease inhibitor for the treatment of hepatitis C virus infection.
    Njoroge FG; Chen KX; Shih NY; Piwinski JJ
    Acc Chem Res; 2008 Jan; 41(1):50-9. PubMed ID: 18193821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naphthyl and coumarinyl biarylpiperazine derivatives as highly potent human beta-secretase inhibitors. Design, synthesis, and enzymatic BACE-1 and cell assays.
    Garino C; Tomita T; Pietrancosta N; Laras Y; Rosas R; Herbette G; Maigret B; Quéléver G; Iwatsubo T; Kraus JL
    J Med Chem; 2006 Jul; 49(14):4275-85. PubMed ID: 16821787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of a conformational change in the human cytomegalovirus protease upon binding of peptidyl-activated carbonyl inhibitors.
    Bonneau PR; Grand-Maître C; Greenwood DJ; Lagacé L; LaPlante SR; Massariol MJ; Ogilvie WW; O'Meara JA; Kawai SH
    Biochemistry; 1997 Oct; 36(41):12644-52. PubMed ID: 9376371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of potent inhibitors of human beta-secretase. Part 2.
    Freskos JN; Fobian YM; Benson TE; Moon JB; Bienkowski MJ; Brown DL; Emmons TL; Heintz R; Laborde A; McDonald JJ; Mischke BV; Molyneaux JM; Mullins PB; Bryan Prince D; Paddock DJ; Tomasselli AG; Winterrowd G
    Bioorg Med Chem Lett; 2007 Jan; 17(1):78-81. PubMed ID: 17049233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and cycloxygenase inhibitory properties of new naphthalene-methylsulfonamido, naphthalene-methylsulfonyl and tetrahydronaphthalen-methylsulfonamido compounds.
    Nencetti S; Ciccone L; Rossello A; Nuti E; Milanese C; Orlandini E
    J Enzyme Inhib Med Chem; 2015 Jun; 30(3):406-12. PubMed ID: 25089708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetrahydroquinoline sulfonamides as gamma-secretase inhibitors.
    Asberom T; Bara TA; Clader JW; Greenlee WJ; Guzik HS; Josien HB; Li W; Parker EM; Pissarnitski DA; Song L; Zhang L; Zhao Z
    Bioorg Med Chem Lett; 2007 Jan; 17(1):205-7. PubMed ID: 17046254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationship of benzo[b]thiophene-2-sulfonamide derivatives as novel human chymase inhibitors.
    Masaki H; Mizuno Y; Tatui A; Murakami A; Koide Y; Satoh S; Takahashi A
    Bioorg Med Chem Lett; 2003 Nov; 13(22):4085-8. PubMed ID: 14592513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene, II: Synthesis and pharmacological investigation of N-substituted trans-2-amino-3-hydroxy-5,8-dimethoxy-1,2,3,4-tetrahydronaphthalenes (author's transl)].
    Dantchev D; Christova K; Staneva D; Rainova L; Tschakarova L
    Arch Pharm (Weinheim); 1977 May; 310(5):369-79. PubMed ID: 869687
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis and SAR of succinamide peptidomimetic inhibitors of cathepsin S.
    Chatterjee AK; Liu H; Tully DC; Guo J; Epple R; Russo R; Williams J; Roberts M; Tuntland T; Chang J; Gordon P; Hollenbeck T; Tumanut C; Li J; Harris JL
    Bioorg Med Chem Lett; 2007 May; 17(10):2899-903. PubMed ID: 17382545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The design and development of 2-aryl-2-hydroxy ethylamine substituted 1H,7H-pyrido[1,2,3-de]quinoxaline-6-carboxamides as inhibitors of human cytomegalovirus polymerase.
    Tanis SP; Strohbach JW; Parker TT; Moon MW; Thaisrivongs S; Perrault WR; Hopkins TA; Knechtel ML; Oien NL; Wieber JL; Stephanski KJ; Wathen MW
    Bioorg Med Chem Lett; 2010 Mar; 20(6):1994-2000. PubMed ID: 20167488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of fragment screening and fragment linking to the discovery of novel thrombin inhibitors.
    Howard N; Abell C; Blakemore W; Chessari G; Congreve M; Howard S; Jhoti H; Murray CW; Seavers LC; van Montfort RL
    J Med Chem; 2006 Feb; 49(4):1346-55. PubMed ID: 16480269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.